Finance
Pacific Biosciences surges on $1.2 billion takeover offer from DNA sequencing company Illumina (ILMN, PACB)
- DNA sequencing company Illumina announced in a press release that it was acquiring Pacific Biosciences for approximately $1.2 billion. Illumina expects to close the transaction in mid-2019.
- Illumina offered $8 a share for Pacific Biosciences. Pacific Biosciences shares jumped 67% in late trading to $7.51
- Pacific Biosciences is a company that also specializes in gene sequencing. Pacific Biosciences CEO Michael Hunkapiller said in the press release that the two companies have complementary technology capabilities for analyzing genes, and when combined, will open “new frontiers of genomic utility.”
Continue Reading
-
Business7 days ago
UnitedHealth says Change hackers stole health data on ‘substantial proportion of people in America’
-
Business6 days ago
Tesla’s new growth plan is centered around mysterious cheaper models
-
Business5 days ago
Xaira, an AI drug discovery startup, launches with a massive $1B, says it’s ‘ready’ to start developing drugs
-
Business5 days ago
UK probes Amazon and Microsoft over AI partnerships with Mistral, Anthropic, and Inflection
-
Entertainment3 days ago
Summer Movie Preview: From ‘Alien’ and ‘Furiosa’ to ‘Deadpool and Wolverine’
-
Business6 days ago
Two widow founders launch DayNew, a social platform for people dealing with grief and trauma
-
Entertainment6 days ago
Tesla’s in trouble. Is Elon Musk the problem?
-
Business4 days ago
Petlibro’s new smart refrigerated wet food feeder is what your cat deserves